BD1 Outlook, page-143

I rang the CEO or whoever I spoke to at BD1 a while ago when I was holding stock. I asked about the Vaccine tests etc and nudged and winked all I could to get a hint of whats what.

She just said, The Vaccine tests and development is in the early stages and its a much slower path to get a Vaccine approved than it is a test for Lung/breast cancer etc that is much further advanced in its develpment, and is a much shorter path to get a blood test approved than getting a vaccine approved.

So The Vaccine is a slower path say 5 years etc, and its early stages of development.

The other stuff they are doing is much further developed, and is a much shorter path to approval than a Vaccine.

So Based on that taking the hype off my assumptions in the Vaccine, I agreed with others that this would trade at or belw 2c, so I took the hit and got out at 2.7c.

But there was some kind of wink nudge that there could be some good news early in 2019 to give it a bump.

So based on that , Im still waiting for a buy back in, and Im not sure what y'all reckon will be the base here.